Resources

The importance of early immunotherapy in patients with faciobrachial dystonic seizures February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5837230/

Learn more
Extreme delta-with or without brushes: a potential surrogate marker of disease activity in anti-NMDA receptor encephalitis February 27, 2021

http://www.clinph-journal.com/article/S1388-2457(18)30239-6/fulltext

Learn more
Delayed LGI1 seropositivity in voltage-gated potassium channel (VGKC)-complex antibody limbic encephalitis February 27, 2021

http://casereports.bmj.com/content/2017/bcr-2016-218893.full

Learn more
Persistence of parenchymal and perivascular T-cells in treatment-refractory anti-N-methyl-D-aspartate receptor encephalitis February 27, 2021

https://www.ncbi.nlm.nih.gov/pubmed/28777260

Learn more
Autoimmune encephalitis with anti-leucine-rich glioma-inactivated 1 or anti-contactin-associated protein-like 2 antibodies (formerly called voltage-gated potassium channel-complex antibodies). February 27, 2021

https://insights.ovid.com/pubmed?pmid=28248701

Learn more
Autoimmune encephalitis: pathophysiology and imaging review of an overlooked diagnosis February 27, 2021

http://www.ajnr.org/content/38/6/1070.long

Learn more
Innate and adaptive immunity in human epilepsies February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5535008/

Learn more
DPPX antibody-associated encephalitis, main syndrome and antibody effects February 27, 2021

http://n.neurology.org/content/88/14/1340.long

Learn more
The need of standardization and of large clinical studies in an emerging indication of FDG PET: the autoimmune encephalitis February 27, 2021

https://link.springer.com/article/10.1007%2Fs00259-016-3589-9

Learn more
The value of LGI1, Caspr2 and voltage-gated potassium channel antibodies in encephalitis February 27, 2021

https://www.nature.com/articles/nrn Febeurol.2017.43

Learn more